Psychedelic Stocks,Shroom News Cybin Announces New York Stock Exchange Conditional Listing Approval By Dennis Mutua July 23, 2021 Biotechnology company focusing on progressing psychedelic therapeutics by utilizing drug discovery and delivery for various psychiatric and neurological conditions Cybin Inc. (NEO: CYBN) (OTCMKTS: CLXPF) announced having received ...
Psychedelic Stocks,Shroom News Small Pharma Launches a Psychedelic-Assisted Therapy Program By Dennis Mutua July 22, 2021 Neuropharmaceutical company developing novel rapid-acting treatments for depression and mental health conditions Small Pharma Inc. (TSXV: DMT) announced launching of psychedelics assisted therapy training program. The company h...
Psychedelic Stocks,Shroom News Levitee Labs To Start Trading on Canadian Securities Exchange By Dennis Mutua July 21, 2021 Emerging multidisciplinary integrative wellness company seeking to redefine mental healthcare through evidence-based medicines and novel psychedelics therapies Levitee Labs Inc. is set to start trading on the Canadian Securities E...
Psychedelic Stocks,Shroom News Octarine Bio Expands its Scientific Advisory Board By Dennis Mutua July 20, 2021 Sythentic biotechnology company developing biosynthetic platform to speed development of cannabinoid and psychedelic therapeutics Octarine Bio announced having expanded its scientific advisory board. This expansion entails addi...
Shroom News,Spotlight Stock Third Psychedelics Exchange-Traded Fund Set to be Launched Soon By Dennis Mutua July 19, 2021 A third psychedelics exchange-traded fund (ETF) is expected to be launched soon on the New York Stock Exchange Arca. This exchange-traded fund is set to be different from the others since it will be actively managed which will ...
Psychedelic Stocks,Shroom News Creso Pharma completes Acquisition of Halucenex Life Sciences By Dennis Mutua July 16, 2021 Pharmaceutical company engaging in development of cannabis derived therapeutic, nutraceutical, and human and animal lifestyle products Creso Pharma Ltd. (ASX: CPH) announced having completed acquisition of life sciences company fo...
Psychedelic Stocks,Shroom News Optimi Health Enters First Ever Psychedelic Exchange Traded Fund By Dennis Mutua July 15, 2021 Health wellness company focusing on integrating functional mushrooms products and making psychedelics products easily available to those in need Optimi Heath Corp. (CSE: OPTI) (OTC: OPTHF) has joined the first ever psychedelics ex...
Psychedelic Stocks,Shroom News MindCure Submits Patent Application For Its First Innovative Process of Synthesizing Ibogaine Psychedelic Compound By Dennis Mutua July 14, 2021 Mental wellness company specializing on investigating the potential of psychedelics compounds MindCure Health Inc. (CSE: MCUR) (OTCQB: MCURF) announced having submitted a provisional patent application with the United States Paten...